21/168US=7 / Biol/Mol
Jenkins J, Masny A, Tranin AS. Genetics in oncology practice: cancer risk assessment. Pittsburgh: Oncology Nursing Society, 2005. 336 p. ISBN 978-1-890504-31-9.

22/168US=24 / Pélvis
Rozen P, Levin B, Young GP,. Who are at risk from familial colorectal cancer and how can they be managed?. In: Rozen P, Young GP, Levin B, Spann SJ. Colorectal cancer in clinical practice: prevention, early detection and management. 2ª ed. New York: Taylor & Francis, 2006. p. 67-84.

TENDENCIAS/TEMPO; FATORES DE RISCOS COLORETAL CANCER; DIAGNOSTICO; MORTALIDADE; TERMINOLOGIA USADA; SIGMOIDOSCOPIA; SINAIS E SINTOMAS/CANCER COLORETAL


23/168US=15 / Mama
Goldstein NS, Ziegfekd CR. Risk factores and risk assessment. In: Jacobs L, Finlayson CA. Breast cancer. Philadelphia: Saunders Elsevier, 2011. p. 55-69. (Early Diagnosis and Treatment of Cancer) ISBN 978-1-4160-4932-6.

FATORES DE RISCOS; AVALIACAO DE RISCOS; CANCER DE MAMA. RISCO; FATORES DE RISCO; FERRAMENTAS DE AVALIACAO


24/168US=15 / Mama
Voltura A, Jacobs L. Strategies for risk reduction. In: Jacobs L, Finlayson CA. Breast cancer. Philadelphia: Saunders Elsevier, 2011. p. 89-103. (Early Diagnosis and Treatment of Cancer) ISBN 978-1-4160-4932-6.

CANCER DE MAMA; REDUCAO DE RISCO; QUIMIOPREVENCAO; DOENCAS BENIGMA DA MAMA; MASTECTOMIA PROFILATICA


25/168US=15 / Mama
Borgstede JP, Bagrosky BM. Screening of high-risk patients. In: Jacobs L, Finlayson CA. Breast cancer. Philadelphia: Saunders Elsevier, 2011. p. 141-149. (Early Diagnosis and Treatment of Cancer) ISBN 978-1-4160-4932-6.

CANCER DE MAMA; PACIENTES DE ALTO RISCO; MAMOGRAFIA


26/168US=18 / Pélvis
Chu KM. Epidemiology and risk factors of colorectal cancer. In: Gearhart SL, Ahuja N. Colorectal cancer. Philadelphia: Elsevier Saunders, 2011. p. 1-11. (Early Diagnosis and Treatment of Cancer) ISBN 978-1-4160-4686-8.

CANCER COLORRETAL; CANCER COLORRETAL. EPIDEMIOLOGIA; CANCER DE COLON E RETO. TIPOS; CANCER COLORRETAL. INCIDENCIA; CANCER COLORRETAL. FATORES DE RISCO; FATORES GENETICOS; FATORES AMBIENTAIS; MORTALIDADE


27/168US=1 / Gastro
Groopman JD, Brodovicz K, Kensler TW. Environmental carcinogens and risk for human liver cancer. In: Carr BI. Hepatocellular carcinoma: diagnosis and treatment. New York: Humana Press, 2010. p. 27-53. ISBN 978-1-60327-373-2.

CARCINOGENOS AMBIENTAIS; CANCER DE FIGADO HUMANO. RISCOS; CARCINOMA HEPATOCELULAR; COLANGIOCARCINOMAS; CARCINOMAS DE VIAS BILIARES; VIRUS DA HEPATITE B; VIRUS DA HEPATITE C


28/168US=25 / Mama
Khan SA, Gapstur SM, Gapstur SM. Management of other high risk patients. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. 4ªed. Philadelphia: Lippincott Williams & Wilkins, 2010. p. 291-301. ISBN 978-0-7817-9117-5.

PACIENTE. ALTO RISCO; MULHERES. ALTO RISCO; RISCO PARA CANCER DE MAMA ESPORADICO; CANCER DE MAMA. FATORES E RISCOS


29/168US=9 / Urologia
Chan JM, Richman EL. Diet and prostate cancer incidence, recurrence, and progression risk. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 363-73. ISBN 978-1-60327-831-7.

DIETA; NUTRICAO; CANCER DE PROSTATA


30/168US=23-E / Câncer
Richiardi L, Maule MM. Survivors of germ-cell testicular cancer: increased risk of second primary tumors. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 181-91. ISBN 978-90-481-2917-1.

GERMES; CELULAS DE CANCER TESTICULAR; TUMOR PRIMARIO


31/168US=23-F / Câncer
Shah NG, Trivedi TI. Early stage oral squamous cell carcinoma: use of signal transducer and activator of transcription 3 as a risk factor for poor diagnosis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 237-53. ISBN 978-90-481-3185-3.

CARCINOMA DE CELULAS ESCAMOSAS ORAL; USO DE TRANSDUTOR DE SINAL; FATOR 3 ATIVADOR DA TRANSCRICAO


32/168US=11 / Tórax
Muers M, Hunt I, Fox J. Epidemiology, risk factors and prevention. In: Hunt I, Muers M, Treasure T. ABC of lung cancer. New Jersey: John Wiley & Sons, 2009. p. 1-5. (ABC Series) ISBN 978-1-4051-4652-4.

CANCER DE PULMAO. EPIDEMIOLOGIA; CANCER DE PULMAO. FATORES DE RISCO; CANCER DE PULMAO. PREVECAO; TABAGISMO


33/168US=13 / Tórax
John TMS. Environmetal risk: indoor radon exposure. In: Haas ML. Contemporary issues in lung cancer: a nursing perspective. 2ª ed. Boston: Jones and Bartlett Publishers, 2010. p. 217-29. ISBN 978-0-7637-6051-9.

CANCER DE PULMAO; RADAO; RADON; RADIOATIVIDADE; RECURSOS DE RADONIO; PRATICA DE ENFERMAGEM


34/168US=14 / Dermatologia
Dantal J. De novo post-transplantation malignancies: incidence and risk factors. In: Ulrich ESC, Euvrard S, Proby C, Bavinck JNB, Geissler EK. Skin cancer after organ transplantation. New York: Springer, 2009. p. 11-21. (Cancer Treatment and Reseach) ISBN 978-0-387-78573-8.

CANCER POS-TRANSPLANTE. INCIDENCIA; CANCER POS-TRANSPLANTE. FATORES DE RISCO; TRANSPLANTE RENAL; TRANSPLANTE DE PULMAO; TRANSPLANTE DE CORACAO; TRANSPLANTE DE FIGADO


35/168US=16 / Nutrição
Caruso L, Marucci MFN. Triagem nutricional: abordagem na prática clínica. In: Rossi L, Caruso L, Galante Ap. Avaliação nutricional: novas perspectivas. São Paulo: Roca, 2009. p. 13-22. ISBN 85-7241-762-4.

TRIAGEM NUTRICIONAL; TRIAGEM NUTRICIONAL NA UNIDADE HOSPITALAR; TRIAGEM NUTRICIONAL. HISTORICO; TRIAGEM NUTRICIONAL. METODOS; AVALIACAO NUTRICIONAL SUBJETIVA; METODO DE TRIAGEM NUTRICIONAL; METODO MALNUTRITION UNIVERSAL SCREENING TOOL; METODO NUTRITION RISK SCREENING; METODO MALNUTRITION SCREENING TOOL; METODO NUTRITIONAL ASSESSMENT QUESTIONNAIRE


36/168US=16 / Estatística
Singh KK, Kulawiec M. Mitochondrial DNA polymorphism and risk of cancer. In: Verma M. Cancer epidemiology. New York: Humana Press, 2009. p. 291-303. (Methods in Molecular Biology, 471) ISBN 978-1-58829-987-1.

POLIMORFISMO DE DNA MITOCONDRIAL; RISCO DE CANCER; APOPTOSE; MITOCONDRIA; FOSFORILACAO OXIDATIVA; POLIMORFISMO; ESPECIES REATIVAS DE OXIGENIO


37/168US=16 / Estatística
Jiang J, Zhang X, Yang H, Wang W. Polymorphisms of DNA repair genes: ADPRT, XRCC1, and XPD and cancer risk in genetic epidemiology. In: Verma M. Cancer epidemiology. New York: Humana Press, 2009. p. 305-33. (Methods in Molecular Biology, 471) ISBN 978-1-58829-987-1.

POLIMORFISMOS; GENES DE REPARO DO DNA; ADPRT; XRCC1; XPD; RISCO DE CANCER; EPIDEMIOLOGIA GENETICA


38/168US=16 / Estatística
Xu XC. Risk factors and gene expression in esophageal cancer. In: Verma M. Cancer epidemiology. New York: Humana Press, 2009. p. 335-60. (Methods in Molecular Biology, 471) ISBN 978-1-58829-987-1.

CANCER DE ESOFAGO; FATORES DE RISCO; EXPRESSAO GENICA; TABAGISMO; ALCOOLISMO; REFLUXO GASTROESOFAGICO; ALTERACOES GENETICAS; CANCER. PREVENCAO; ESOFAGO DE BARRET; ADENOCARCINOMA ESOFAGICO; MUTACAO DO GENE P53; ALTERACAO DO GENE P16; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMAL (EGFR); CADERINA-E; COX-2; QUIMIOPREVENCAO; ACIDOS RETINOICOS; ANTI-INFLAMATORIOS NAO ESTEROIDES; EGCG; CURCUMINA


39/168US=16 / Estatística
Park JY, Huang Y, Sellers TA. Single nucleotide polymorphisms in DNA repair genes and prostate cancer risk. In: Verma M. Cancer epidemiology. New York: Humana Press, 2009. p. 361-85. (Methods in Molecular Biology, 471) ISBN 978-1-58829-987-1.

REPARO DE DNA; POLIMORFISMO; EXPOSICAO AMBIENTAL; CANCER DE PROSTATA; SUSCETIBILIDADE AO CANCER


40/168US=23 / Patologia
Farhi DC. Risk factors for hematopoietic neoplasia. In: ___. Pathology of bone marrow and blood cells. 2ªed. Philadelphia: Lippincott Willians & Wilkins, 2009. p. 187-91. ISBN 978-0-7817-7093-4.

NEOPLASIA HEMATOPOIETICA. FATORES DE RISCO


Primeira | Anterior | Próxima | Última